Cancer researchers have long known that prostate cancer tends to be more common, more aggressive and more resistant to existing treatments in African Americans than in Caucasian Americans, but they’re only beginning to understand why.
The Biden administration has left NIH in a weakened state, intensifying politicization of science on Capitol Hill and eroding the bipartisan support the government’s premier biomedical research agency has traditionally enjoyed.
